Cargando…

Additional Value of 2-[(18)F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer Patients

Accurate staging and treatment planning are imperative for precise management in Anal Cancer (ACa) patients. We aimed to evaluate the additive and prognostic value of pre-treatment 2-[(18)F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (2-[(18)F]FDG PET/CT) in the staging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manafi-Farid, Reyhaneh, Kupferthaler, Alexander, Wundsam, Helwig, Gruber, Georg, Vali, Reza, Venhoda, Clemens, Track, Christine, Beheshti, Ali, Langsteger, Werner, Geinitz, Hans, Beheshti, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563850/ https://www.ncbi.nlm.nih.gov/pubmed/32842617 http://dx.doi.org/10.3390/jcm9092715

Ejemplares similares

Diagnostic Performance of [(18)F]Fluorocholine and [(68)Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
por: Paymani, Zeinab, et al.
Publicado: (2020)

Value of FDG PET/CT in the assessment of patients with colon cancer comparing to stand-alone CT
por: Akbari, Kaveh, et al.
Publicado: (2014)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022)

Prospects of conservative treatment for Clostridium septicum–associated aortitis
por: Kirchweger, Patrick, et al.
Publicado: (2022)

(18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients
por: Beheshti, Mohsen, et al.
Publicado: (2018)

Factors predicting biochemical response and survival benefits following radioligand therapy with [(177)Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2021)

Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2021)

Feasibility of equivalent performance of 3D TOF [(18)F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters
por: Pilz, Julia, et al.
Publicado: (2021)

Hepatic candidiasis mimicking lymphoma on (18)F-FDG PET/CT in a patient with T cell lymphoma
por: Schwerz, Sandra, et al.
Publicado: (2020)

Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
por: Beheshti, Mohsen, et al.
Publicado: (2022)

Diagnostic Value of 2-[(18)F]FDG PET/CT in a Patient with Atypical Subacute Thyroiditis: A Case Report
por: Kraus, Teresa, et al.
Publicado: (2022)

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

Predictive value and accuracy of [(18)F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
por: Ayati, Narjess, et al.
Publicado: (2023)

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2023)

FLAIR-Wise Machine-Learning Classification and Lateralization of MRI-Negative (18)F-FDG PET-Positive Temporal Lobe Epilepsy
por: Beheshti, Iman, et al.
Publicado: (2020)

Monitoring Alzheimer’s Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods
por: Beheshti, Iman, et al.
Publicado: (2022)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Impact of [(18)F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
por: Ranjbar, Shaghayegh, et al.
Publicado: (2023)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Accurate detection of intracranial extension of jugulotympanic paraganglioma by [(18)F]FDOPA-PET/CT comparing to MRI
por: Araghi, Zahra Jamshidi, et al.
Publicado: (2021)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma
por: Krengli, Marco, et al.
Publicado: (2010)

Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020)

Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients
por: Slim, Najla, et al.
Publicado: (2020)

FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience
por: Di Carlo, Clelia, et al.
Publicado: (2021)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
por: Jones, Michael Peter, et al.
Publicado: (2019)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Special Issue: Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
por: Beheshti, Mohsen, et al.
Publicado: (2021)

Endoscopic Transmural Therapy of Pancreatic Fistulas in an Interdisciplinary Setting—A Retrospective Data Analysis
por: Meierhofer, Clara, et al.
Publicado: (2023)

Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT
por: Brown, P. J., et al.
Publicado: (2019)

A pilot study investigating the role of (18)F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer
por: Smith, Drew, et al.
Publicado: (2022)

Evolving Role of [(18)F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach?
por: Seyedinia, Seyedeh Sara, et al.
Publicado: (2023)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Practice of radiation therapy for anal cancer in Austria—a survey on behalf of the Austrian radiation oncology society gastrointestinal tumor group (ÖGRO-GIT)
por: Gerum, S., et al.
Publicado: (2021)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Cocaine Destroys Gray Matter Brain Cells and Accelerates Brain Aging
por: Beheshti, Iman
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9fq5rvk7n9uqctkoqepr905gh